Tags: Drug.
Drisapersen (also known as PRO051 and GSK2402968) is an experimental drug that was under development by Prosensa for the treatment of Duchenne muscular dystrophy. The drug is a 2′-O-methyl phosphorothioate oligonucleotide that alters the splicing of the dystrophin RNA transcript eliminating exon 51 from the mature dystrophin mRNA.The compound has completed Phase III trials and did not meet its primary endpoint.